APA

De Kam P., Kruithof A. C., van Lierop M., Moerland M., Dennie J., Troyer M. D., Langdon R. B., Gutstein D. E., Burggraaf J. & El Galta R. (20140925). Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects. : International journal of clinical pharmacology and therapeutics.

Chicago

De Kam Pieter-Jan, Kruithof Annelieke C, van Lierop Marie-José, Moerland Matthijs, Dennie Justin, Troyer Matthew D, Langdon Ronald B, Gutstein David E, Burggraaf Jacobus and El Galta Rachid. 20140925. Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects. : International journal of clinical pharmacology and therapeutics.

Harvard

De Kam P., Kruithof A. C., van Lierop M., Moerland M., Dennie J., Troyer M. D., Langdon R. B., Gutstein D. E., Burggraaf J. and El Galta R. (20140925). Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects. : International journal of clinical pharmacology and therapeutics.

MLA

De Kam Pieter-Jan, Kruithof Annelieke C, van Lierop Marie-José, Moerland Matthijs, Dennie Justin, Troyer Matthew D, Langdon Ronald B, Gutstein David E, Burggraaf Jacobus and El Galta Rachid. Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects. : International journal of clinical pharmacology and therapeutics. 20140925.